| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $740 | -53.4% | — |
| Cost of Revenue | $292 | -59.6% | — |
| Gross Profit | $448 | -48.2% | — |
| R&D Expense | $0 | — | — |
| SG&A Expense | $1000K | +4587.7% | +540.6% |
| Operating Income | -$999K | -51.5% | -540.3% |
| Net Income | -$1.0M | -54.2% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $16K | — | — |
| Inventory | $13K | — | — |
| Current Assets | $46K | — | — |
| Total Assets | $3.2M | — | — |
| Current Liabilities | $570K | — | — |
| Long-term Debt | $131K | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$632K | — | — |
| Investing Cash Flow | $609K | — | — |
| Financing Cash Flow | $179K | — | — |
| -552.4% |
| EPS (Basic) | -$0.08 | -60.0% | — |
| EPS (Diluted) | -$0.08 | -60.0% | — |
| — |
| Total Liabilities | $572K | — | — |
| Stockholders' Equity | $2.6M | -16.3% | -37.0% |